PATENT CLAIM ANALYSIS

Application Number: 16205848
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["514", "249000"]

Abstract:
The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.

Claim (Index 12):
A method of treating a disease, disorder or condition in a subject, the method comprising administering to the subject a compound or pharmaceutically acceptable salt thereof as defined in  claim 1 , wherein the disease, disorder or condition is selected from Parkinson's disease, levodopa induced dyskinesias, Huntington's disease, drug addiction, eating disorders, cognitive disorders, schizophrenia, bipolar disorders, and depression.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15118447', '14577480', '14421516', '15334198', '14883174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7676361402536012
- 35 USC 102 Novelty (BERT): 0.6210319688084058
- Combined Prediction Score: 0.7529757231090816
- Mean Citation Score: 421.93131
- Max Citation Score: 625.6801
- Similarity Product: 484.1329226739288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test